Association Between Achievement of Clinical Disease Control and Improvement in Patient-Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 SELECT-PsA 1 and 2 Randomized Controlled Trials.
Arthur KavanaughPhillip J MeaseLaure GossecRoberto RanzaShigeyoshi TsujiKevin DouglasMichael LaneRalph LippeManish MittalTianming GaoArathi SettySandra CiecinskiDaniel AletahaPeter NashPublished in: ACR open rheumatology (2024)
Patients with PsA who achieve clinical disease control are more likely to achieve improvements and normative values in PROs and QoL measures, which reinforces disease control as a treatment target.